8.44
Schlusskurs vom Vortag:
$8.24
Offen:
$7.83
24-Stunden-Volumen:
5,507
Relative Volume:
0.00
Marktkapitalisierung:
$4.83M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-15.42M
KGV:
-4.587
EPS:
-1.84
Netto-Cashflow:
$-13.41M
1W Leistung:
+16.90%
1M Leistung:
-29.67%
6M Leistung:
+978.04%
1J Leistung:
+405.39%
Indaptus Therapeutics Inc Stock (INDP) Company Profile
Firmenname
Indaptus Therapeutics Inc
Sektor
Branche
Telefon
(646) 427-2727
Adresse
3 COLUMBUS CIRCLE, NEW YORK
Vergleichen Sie INDP mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
INDP
Indaptus Therapeutics Inc
|
8.44 | 8.72M | 0 | -15.42M | -13.41M | -1.84 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 96.01B | 11.42B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 57.86B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 57.02B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
646.60 | 39.10B | 3.05B | 1.28B | -614.78M | 19.58 |
![]()
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.45B | 3.81B | -644.79M | -669.77M | -6.24 |
Indaptus Therapeutics Inc Aktie (INDP) Neueste Nachrichten
Does Indaptus Therapeutics Inc. qualify in momentum factor screeningEarnings Miss & High Conviction Investment Ideas - Newser
Indaptus Therapeutics reports Q2 EPS ($9.09) vs ($13.16) last year - TipRanks
Indaptus Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update - The Manila Times
Indaptus Therapeutics Q2 2025 Financial Results and Corporate Update - TradingView
Indaptus Therapeutics, Inc. SEC 10-Q Report - TradingView
Press Release: Indaptus Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update - 富途牛牛
What to expect from Indaptus Therapeutics Inc. in the next 30 daysJuly 2025 PostEarnings & Community Trade Idea Sharing Platform - Newser
Price momentum metrics for Indaptus Therapeutics Inc. explainedJuly 2025 Patterns & Community Supported Trade Ideas - Newser
Indaptus Therapeutics Inc. stock prediction for this weekQuarterly Trade Report & Trade Opportunity Analysis Reports - Newser
How to use a screener to detect Indaptus Therapeutics Inc. breakouts2025 Market Sentiment & AI Driven Stock Movement Reports - Newser
How sentiment analysis helps forecast Indaptus Therapeutics Inc.Equity Signal Recap With Long-Term Summary - Newser
Is Indaptus Therapeutics Inc. stock a growth or value playTrade Ideas & Real-Time Chart Breakout Alerts - Newser
Why Indaptus Therapeutics Inc. stock attracts strong analyst attentionBig Money Stock Playbook - newsyoung.net
What technical models suggest about Indaptus Therapeutics Inc.’s comeback - Newser
How high can Indaptus Therapeutics Inc. stock price go in 2025Trading Watchlist with Real Time Filters - Newser
Will Indaptus Therapeutics Inc. stock recover after recent dropConsistent Return Setup with Exit Strategy - Newser
Indaptus Therapeutics Inc.’s volatility index tracking explainedTrend Analysis for Safer Market Entries - Newser
Applying chart zones and confluence areas to Indaptus Therapeutics Inc.Short-Term Sector Movement Forecast Generator - Newser
Is Indaptus Therapeutics Inc. stock a good hedge against inflationCapital Secure Pattern Signal Analysis Sheet - Newser
Using data models to predict Indaptus Therapeutics Inc. stock movementLong-Term Stock Growth Forecast Insights - Newser
How to escape a deep drawdown in Indaptus Therapeutics Inc.Reversal Pattern Insights with Entry Tips - Newser
Will Indaptus Therapeutics Inc. price bounce be sustainable5-Year Price Trend Summary and Analysis - Newser
How to build a dashboard for Indaptus Therapeutics Inc. stockFuture Growth Stock Forecasting Strategy - Newser
Indaptus Therapeutics (INDP) Projected to Post Earnings on Monday - Defense World
How Indaptus Therapeutics Inc. stock performs during market volatilityBollinger Band Squeeze and Expansion Analysis - Newser
Reviewing BioNxt Solutions (OTCMKTS:BNXTF) and Indaptus Therapeutics (NASDAQ:INDP) - Defense World
Measuring Indaptus Therapeutics Inc.’s beta against major indicesEquity Portfolio Outlook and Performance Summary - Newser
What drives Indaptus Therapeutics Inc. stock priceInvest confidently with data-driven strategies - Jammu Links News
How many analysts rate Indaptus Therapeutics Inc. as a “Buy”Capitalize on market shifts before others do - Jammu Links News
Does Indaptus Therapeutics Inc. stock perform well during market downturnsGet alerts on high-potential stock breakouts - Jammu Links News
When is Indaptus Therapeutics Inc. stock expected to show significant growthExceptional growth trajectory - Jammu Links News
How to read the order book for Indaptus Therapeutics Inc.Secure Buy Strategy Based on Risk Parameters - Newser
Should I hold or sell Indaptus Therapeutics Inc. stock in 2025Unlock daily trading alerts for profits - Jammu Links News
Finanzdaten der Indaptus Therapeutics Inc-Aktie (INDP)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):